Carrai Phillip D 4
4 · KRATOS DEFENSE & SECURITY SOLUTIONS, INC. · Filed Jul 17, 2026
Research Summary
AI-generated summary of this filing
Kratos (KTOS) President Phillip Carrai Sells 6,500 Shares
What Happened
Phillip D. Carrai, President of Kratos' STC Division, sold a total of 6,500 shares of KRATOS (KTOS) in open‑market transactions on July 15, 2026, generating aggregate gross proceeds of approximately $329,105. The sales were executed in five lots: 3,900 shares at a weighted avg $49.79 ($194,169); 700 shares at $50.78 ($35,544); 1,400 shares at $52.05 ($72,870); 400 shares at $52.84 ($21,137); and 100 shares at $53.85 ($5,385). These transactions were effected under a pre‑existing 10b5‑1 trading plan.
Key Details
- Transaction date: July 15, 2026; Form 4 filed July 17, 2026 (appears timely—within the usual two business days).
- Total sold: 6,500 shares for approx. $329,105.
- Price details / ranges (per filing footnotes):
- 3,900 shares: weighted avg $49.79 (range $49.23–$50.20)
- 700 shares: weighted avg $50.78 (range $50.44–$51.03)
- 1,400 shares: weighted avg $52.05 (range $51.59–$52.31)
- 400 shares: weighted avg $52.84 (range $52.59–$53.52)
- 100 shares: $53.85
- Plan disclosure: Transaction effected pursuant to a 10b5‑1 trading plan adopted Aug 26, 2025 (Footnote F1).
- Holdings note: Filing does not list total shares owned after these sales; footnote F6 indicates holdings include 1,232 shares from the ESPP and ~4,577 shares held in the issuer’s 401(k) plan.
- No indication of option exercise, gift, or tax‑withholding in this filing — these were open‑market sales (code S).
Context
Sales under a pre‑arranged 10b5‑1 plan are typically scheduled ahead of time and are common for insiders managing concentration or liquidity; they do not, by themselves, indicate non‑routine or information‑based trading. Retail investors should combine this with other insider activity and company fundamentals before drawing conclusions.
Insider Transaction Report
- Sale
Common Stock
[F1][F2][F6]2026-07-15$49.79/sh−3,900$194,169→ 211,224 total - Sale
Common Stock
[F1][F3][F6]2026-07-15$50.78/sh−700$35,544→ 210,524 total - Sale
Common Stock
[F1][F4][F6]2026-07-15$52.05/sh−1,400$72,870→ 209,124 total - Sale
Common Stock
[F1][F5][F6]2026-07-15$52.84/sh−400$21,137→ 208,724 total - Sale
Common Stock
[F1][F6]2026-07-15$53.85/sh−100$5,385→ 208,624 total
- 46,644(indirect: By Trust)
Common Stock
Footnotes (6)
- [F1]This transaction was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on August 26, 2025.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.23 to $50.20 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.44 to $51.03 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.59 to $52.31 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.59 to $53.52 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- [F6]Includes 1,232 shares purchased through Issuer's Employee Stock Purchase Plan and approximately 4,577 shares held through Issuer's 401(k) Plan.